Hello Heart, a clinically validated heart health and hypertension management app, has completed a $45 million Series C funding round.
IVP (Institutional Venture Partners) led the round. Hello Heart’s existing investors, including Khosla Ventures, BlueRun Ventures, Maven Ventures, and Resolute Ventures, also participated.
As part of the funding, Somesh Dash, General Partner at IVP, will join Hello Heart’s board of directors.
According to Hello Heart, its flagship app helps people manage their blood pressure, pulse, medications, and activity using AI-based technology. The app allows users to track critical health metrics, receive personalized feedback, and take steps to improve their health with clinically proven suggestions. It also enables users to quickly identify a hypertensive crisis or irregular heartbeat, facilitating a timely referral to their doctor to treat and prevent a potentially catastrophic cardiac event, according to the company.
Hello Heart said its revenue had tripled over the last year. And now, the company’s digital heart health management program is offered by enterprise companies, including many Fortune 500 employers, as part of their benefits programs.
“Whether you’re dealing with a preexisting health condition or consider yourself healthy, Hello Heart’s offering can truly save your life,” said Somesh Dash, General Partner at IVP. “The market for heart disease is large, and adoption of digital solutions is accelerating quickly. Hello Heart has an opportunity to become the digital therapeutics leader for all cardiovascular diseases, and we’re excited to partner with them on their growth phase.”
“Hypertension is the most prevalent chronic condition in America, impacting roughly half the US population,” wrote Parsa Saljoughian, Partner at IVP. “Given the opportunity to improve millions of lives and save billions of dollars in healthcare spend, we couldn’t be more thrilled to support the Hello Heart team on the road ahead.”
mHealth companies saw a strong surge in funding activity, raising a record $1.4 billion VC funding in Q1 2021. The funding increased by 94% year-over-year (YoY), compared to $728 million raised in Q1 2020, according to the recently released Mercom’s Q1 2021 Digital Health Funding and M&A Report.
